Bionano Genomics (BNGO) Net Cash Flow (2017 - 2025)
Historic Net Cash Flow for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$493000.0.
- Bionano Genomics' Net Cash Flow rose 9610.68% to -$493000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year increase of 7623.07%. This contributed to the annual value of -$8.8 million for FY2024, which is 16854.28% down from last year.
- Latest data reveals that Bionano Genomics reported Net Cash Flow of -$493000.0 as of Q3 2025, which was up 9610.68% from -$52000.0 recorded in Q2 2025.
- In the past 5 years, Bionano Genomics' Net Cash Flow registered a high of $323.6 million during Q1 2021, and its lowest value of -$191.8 million during Q3 2021.
- Moreover, its 5-year median value for Net Cash Flow was -$523000.0 (2022), whereas its average is -$1.9 million.
- Within the past 5 years, the most significant YoY rise in Bionano Genomics' Net Cash Flow was 363014.07% (2021), while the steepest drop was 1156551.11% (2021).
- Quarter analysis of 5 years shows Bionano Genomics' Net Cash Flow stood at -$116.2 million in 2021, then skyrocketed by 80.41% to -$22.8 million in 2022, then grew by 26.77% to -$16.7 million in 2023, then surged by 102.3% to $383000.0 in 2024, then tumbled by 228.72% to -$493000.0 in 2025.
- Its Net Cash Flow stands at -$493000.0 for Q3 2025, versus -$52000.0 for Q2 2025 and -$6.0 million for Q1 2025.